Rabbit Polyclonal Biglycan antibody. Suitable for WB, IHC-P and reacts with Human samples. Cited in 4 publications. Immunogen corresponding to Recombinant Fragment Protein within Human BGN.
View Alternative Names
SLRR1A, BGN, Biglycan, Bone/cartilage proteoglycan I, PG-S1
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Biglycan antibody (AB226991)
Paraffin-embedded human colon epithelium tissue stained for Biglycan using ab226991 at 1/250 dilution in immunohistochemical analysis.
- WB
Supplier Data
Western blot - Anti-Biglycan antibody (AB226991)
12% SDS-PAGE gel.
All lanes:
Western blot - Anti-Biglycan antibody (ab226991) at 1/500 dilution
All lanes:
HEK-293T (human epithelial cell line from embryonic kidney transformed with large T antigen) whole cell lysate at 30 µg
Predicted band size: 42 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The protein Biglycan influences cellular processes such as growth and differentiation. It is part of a complex network within the ECM that modulates cell signaling. Biglycan interacts with growth factors like transforming growth factor-beta (TGF-beta) and binds to Toll-like receptors (TLRs) affecting immune responses. These capabilities reveal Biglycan’s involvement in tissue development and repair.
Pathways
Extracellular matrix modulation shows a significant role for Biglycan. It is involved in the TGF-beta signaling pathway and the inflammatory pathway mediated by TLRs. Through these pathways Biglycan interacts with proteins such as decorin and fibromodulin contributing to the regulation of collagen fibrillogenesis and inflammatory responses. Its role in these pathways highlights Biglycan’s influence in cellular communication and matrix regulation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
Acta biochimica et biophysica Sinica 57:712-726 PubMed39578715
2024
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 15:1367432 PubMed38994364
2024
Applications
Unspecified application
Species
Unspecified reactive species
Biomacromolecules 25:5786-5797 PubMed38935055
2024
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 22: PubMed34830254
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com